IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook Fiscal Year 2021 revenues increased 242% year-over-year to a record of...

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results Q4 2021 revenues expected to be at least $20 million, an increase of at least 308%...

IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved...

IM Cannabis Closes Acquisition of MYM Nutraceuticals TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. (“IMC” or the “Company”) (NASDAQ:IMCC)(CSE:IMCC), a...

IM Cannabis Announces Pricing of Proposed Public Offering of Securities TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 5, 2021 / IM Cannabis Corp. (“IMC” or the...

IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be...

IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator Combined Company will be a fully-integrated global leader in adult-use recreational and...